Patent ID: 11858984
Assignee: NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 4:
5. The pharmaceutical composition according to claim 1, wherein the antibody or the antibody fragment thereof comprises:
heavy chain variable regions comprising a heavy chain variable region 1 (CDR H1), a heavy chain variable region 2 (CDR H2), and a heavy chain variable region 3 (CDR H3); and
light chain variable regions comprising a light chain variable region 1 (CDR L1), a light chain variable region 2 (CDR L2), and a light chain variable region 3 (CDR L3), wherein the heavy chain variable region 1 (CDR H1) comprises the amino acid sequence set forth in SEQ ID NO: 7,
wherein the heavy chain variable region 2 (CDR H2) comprises the amino acid sequence set forth in SEQ ID NO: 8,
wherein the heavy chain variable region 3 (CDR H3) comprises the amino acid sequence set forth in SEQ ID NO: 9,
wherein the light chain variable region 1 (CDR L1) comprises the amino acid sequence set forth in SEQ ID NO: 22,
wherein the light chain variable region 2 (CDR L2) comprises the amino acid sequence set forth in SEQ ID NO: 23,
wherein the light chain variable region 3 (CDR L3) comprises the amino acid sequence set forth in SEQ ID NO: 24.